|
| |
|
 |
|
|
| [DISPLAY PATENT] |
| |
| |
|
|
| Application no. and date | 13737946.7 (espacenet) (Federated) (European Patent Register), 20130702 | | Patent/reg. no. and date | DK/EP 2867258, 20170628 | | Publication date | 20150506 | | Priority no. and date | US 201261667058 P, 20120702 | | EP pub. no. and date |
EP 2867258 20150506 | | Effective date | | | Applicant/owner | Bristol-Myers Squibb Company, Route 206 and Province Line Road
Princeton, NJ 08543, US | | Applicant ref. no. | V141511DK | | Inventor | LONBERG, Nils, c/o Bristol-Myers Squibb Company
700 Bay Road
Redwood City
California 94063, US,
SRINIVASAN, Mohan, c/o Bristol-Myers Squibb Company
700 Bay Road
Redwood City
California 94063, US | | Representative | Marks & Clerk LLP, 44 rue de la Vallée
BP 1775
L-1017 Luxembourg, LU | | Opponent | | | IPC Class | C07K 16/28 (2006.01) | | Title | OPTIMERING AF HUMANE ANTISTOFFER, DER BINDER LYMFOCYTAKTIVERINGSGEN-3
(LAG-3), OG ANVENDELSER DERAF | | Int. application no. | US2013048999 | | Int. publication no. | WO2014008218 | | Related patent (certificate) | CA 2023 00007 | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
|
